According to the Canadian Adult Obesity Clinical Practice Guidelines , drug therapy for overweight or obesity is indicated only for those with a BMI of 30 kg/m 2 or more, or for those with a BMI of 27 kg/m 2 or more with at least 1 comorbidity
Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks
Food intake data were expressed as energy intake based on the following conversion: CE-2 3.45 kcal g 1 , HFD-32 5.08 kcal g 1 , and liquid diet 0.644 kcal g 1
Pre-Prescription Discussions When you talk to your healthcare provider, there are important things to cover: Medical History: Tell them about your gallbladder surgery, when it was, and any issues
The risk of hypoglycaemia remains low when metformin and GLP-1 receptor agonists are used together without other glucose-lowering medications, as neither typically causes dangerously low blood sugar on their own
Outsourcing facilities under Section 503B had until May 22, 2025
